CR7835A - Uso de levocetiricina para el tratamiento de la rinitis alergica persistente - Google Patents

Uso de levocetiricina para el tratamiento de la rinitis alergica persistente

Info

Publication number
CR7835A
CR7835A CR7835A CR7835A CR7835A CR 7835 A CR7835 A CR 7835A CR 7835 A CR7835 A CR 7835A CR 7835 A CR7835 A CR 7835A CR 7835 A CR7835 A CR 7835A
Authority
CR
Costa Rica
Prior art keywords
treatment
allergic rhinitis
levocetiricine
persistent allergic
persistent
Prior art date
Application number
CR7835A
Other languages
English (en)
Inventor
Revirron Christophe
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32405747&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR7835(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Publication of CR7835A publication Critical patent/CR7835A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere al uso de la levocetiricina para la preparacion de farmacos efectivos para el tratamiento de la rinitis alergica persistente.
CR7835A 2002-12-03 2005-05-11 Uso de levocetiricina para el tratamiento de la rinitis alergica persistente CR7835A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02080064 2002-12-03

Publications (1)

Publication Number Publication Date
CR7835A true CR7835A (es) 2008-12-01

Family

ID=32405747

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7835A CR7835A (es) 2002-12-03 2005-05-11 Uso de levocetiricina para el tratamiento de la rinitis alergica persistente

Country Status (26)

Country Link
US (1) US20060247258A1 (es)
EP (1) EP1569650B1 (es)
JP (1) JP2006509773A (es)
KR (1) KR20050085298A (es)
CN (1) CN1713912A (es)
AT (1) ATE396730T1 (es)
AU (1) AU2003238399B2 (es)
BR (1) BR0316823A (es)
CA (1) CA2506965A1 (es)
CR (1) CR7835A (es)
CY (1) CY1108191T1 (es)
DE (1) DE60321377D1 (es)
DK (1) DK1569650T3 (es)
ES (1) ES2304514T3 (es)
HR (1) HRP20050497B1 (es)
MA (1) MA27530A1 (es)
MX (1) MXPA05005795A (es)
NO (1) NO20053247L (es)
NZ (1) NZ540415A (es)
PL (1) PL377470A1 (es)
PT (1) PT1569650E (es)
RU (1) RU2005121130A (es)
SI (1) SI1569650T1 (es)
TN (1) TNSN05154A1 (es)
WO (1) WO2004050094A1 (es)
ZA (1) ZA200503703B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060484A1 (es) 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) * 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2145410A1 (en) * 1992-09-24 1994-03-31 Nancy M. Gray Compositions for treating allergic disorders using (-) cetirizine
US20030236275A1 (en) * 2002-06-20 2003-12-25 Schering Corporation Treatment methods of nasal congestion and nasal obstruction

Also Published As

Publication number Publication date
HRP20050497B1 (hr) 2008-10-31
JP2006509773A (ja) 2006-03-23
ATE396730T1 (de) 2008-06-15
CA2506965A1 (en) 2004-06-17
MXPA05005795A (es) 2005-08-16
CN1713912A (zh) 2005-12-28
EP1569650A1 (en) 2005-09-07
WO2004050094A1 (en) 2004-06-17
PT1569650E (pt) 2008-06-26
SI1569650T1 (sl) 2008-08-31
US20060247258A1 (en) 2006-11-02
NO20053247D0 (no) 2005-07-01
NO20053247L (no) 2005-07-01
MA27530A1 (fr) 2005-09-01
CY1108191T1 (el) 2012-05-23
BR0316823A (pt) 2005-10-18
HRP20050497A2 (en) 2005-12-31
KR20050085298A (ko) 2005-08-29
RU2005121130A (ru) 2005-12-10
AU2003238399B2 (en) 2009-05-07
PL377470A1 (pl) 2006-02-06
EP1569650B1 (en) 2008-05-28
ES2304514T3 (es) 2008-10-16
NZ540415A (en) 2008-06-30
ZA200503703B (en) 2006-10-25
DK1569650T3 (da) 2008-06-30
AU2003238399A1 (en) 2004-06-23
TNSN05154A1 (en) 2007-05-14
DE60321377D1 (de) 2008-07-10

Similar Documents

Publication Publication Date Title
PA8586001A1 (es) Derivados de indol útiles para el tratamiento de enfermedades
PA8596901A1 (es) Inhibidores de p38 y metodos de uso de ellos
EA200870127A1 (ru) Полициклические производные аминокислот и способы их применения
CR10099A (es) Inmunoglobulinas dirigidas contra nogo
DOP2002000429A (es) Imidazotriazinas
UY28314A1 (es) Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad
PA8657201A1 (es) Compuestos de 3h-oxazolo y 3h-tiazolo [4, 5-d] pirimidin-2-ona 3, 5-disustituida y 3, 5, 7 - trisustituida y profarmacos de los mismos
PA8604301A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
UY27714A1 (es) 2 - heteroaril - pirimidinas inhibidoras de cdk, su preparación y su uso como medicamentos.
CR8649A (es) Derivados de formamidina para el tratamiento de enfermedades
AR048912A1 (es) Inmunoglobulinas anti-nogo
UY28144A1 (es) Agentes terapéuticos
PA8604201A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
ECSP045156A (es) Derivados de indolilalquilamina como ligandos 5-hidroxitriptamina-6
PA8603001A1 (es) Compuestos utiles para el tratamiento de enfermedades
HN2003000379A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes
HN2002000365A (es) Lactamas como antagonistas de taquiquininas
UY28377A1 (es) Agentes terapeuticos
UY28313A1 (es) Nonadepsipeptidos acilados
PA8627001A1 (es) Compuestos para el tratamiento de enfermedades
ES2340502T3 (es) Compuestos de 1,4,8-triazaespiro(4,5)decan-2-ona sustituidos para el tratamiento de la obesidad.
ECSP055980A (es) Oxazolidinonas de indolona y derivados de las mismas
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
ECSP056006A (es) Composiciones farmacéuticas que comprenden una combinación de rapamicina o su derivado y pimecrolimus para el tratamiento de enfermedades inflamatorias e inmunológicamente mediadas
HN2003000104A (es) Derivados de ciclopenteno